The Qualcomm Arm trial has brought a long-running technology dispute back into the spotlight, with major questions surrounding chip licensing, contract obligations, royalty payments, and the future relationship between two important semiconductor companies. The latest case began in Delaware on October 5, 2026, and focuses on claims brought by Qualcomm against Arm.
What Is the Qualcomm Arm Dispute About?
The Arm Qualcomm dispute centers on agreements governing access to Arm’s technology. Qualcomm claims that Arm failed to meet certain contractual obligations, including providing chip-testing tools, and that Arm’s actions affected Qualcomm’s business discussions with other companies.
Qualcomm is also challenging issues connected to Arm’s attempt to terminate a key license agreement and its approach to future licensing terms. Arm has rejected Qualcomm’s allegations and is defending its position in court.
Why the Qualcomm Arm Case Matters
The Qualcomm Arm case is important because licensing agreements play a central role in the semiconductor industry. Arm develops processor architectures that are widely used by chip companies, while Qualcomm designs processors for smartphones, computers, vehicles, and other connected products.
The dispute could therefore have implications beyond the two companies. A ruling on contractual rights, licensing conditions, and royalty payments could influence how major technology companies negotiate access to semiconductor technology.
Royalty Payments Are a Major Issue
One of the most significant parts of the trial involves royalties. Qualcomm is seeking to suspend royalty payments to Arm for up to five years. According to Reuters, the potential value of the requested relief could reach billions of dollars.
Qualcomm has also argued that Arm’s licensing terms and negotiations have created financial and commercial concerns. Arm, however, disputes Qualcomm’s claims and argues that the alleged business losses are not supported by the facts.
The Earlier Arm Qualcomm Reviews and Legal Battle
The current proceedings should not be confused with the earlier Arm Qualcomm litigation involving Nuvia. Qualcomm acquired Nuvia in 2021, leading to a separate dispute over whether Nuvia’s Arm licensing rights transferred to Qualcomm.
In December 2024, a jury found that Qualcomm had not breached Nuvia’s architecture license agreement and that Qualcomm’s CPUs using designs acquired through Nuvia were covered by Qualcomm’s own agreement. In September 2025, the district court entered final judgment in favor of Qualcomm and Nuvia on the remaining claim. Arm subsequently appealed.
What It Could Mean for Arm Qualcomm Processor Technology
The dispute also matters for the future of the Arm Qualcomm processor relationship. Qualcomm relies on Arm-based technology across several product categories, while Arm benefits from licensing its architecture to major chipmakers.
The trial could shape discussions around future licensing terms, technology access, royalties, and commercial negotiations. It may also influence how other semiconductor companies approach long-term architecture agreements.
A High-Stakes Test for Chip Licensing
The Qualcomm Arm trial demonstrates how closely technology innovation and contractual rights are connected in the semiconductor industry. Both companies have strong commercial interests in maintaining their positions while protecting their technology and licensing models.
As the trial continues, the industry will be watching whether the court changes the balance between Qualcomm’s licensing rights and Arm’s control over its technology. The outcome could become an important reference point for future chip licensing agreements and partnerships
Read our latest interview with Magdalena Cuprys
